{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T07:55:25Z","timestamp":1768550125647,"version":"3.49.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.vaccine.2005.07.105","type":"journal-article","created":{"date-parts":[[2005,8,23]],"date-time":"2005-08-23T18:13:25Z","timestamp":1124820805000},"page":"263-271","source":"Crossref","is-referenced-by-count":38,"title":["Maternal treatment with a high dose of CpG ODN during gestation alters fetal craniofacial and distal limb development in C57BL\/6 mice"],"prefix":"10.1016","volume":"24","author":[{"given":"M. Renee","family":"Prater","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor J.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dori R.","family":"Germolec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael I.","family":"Luster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven D.","family":"Holladay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vaccine.2005.07.105_bib1","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1006\/smim.1998.0136","article-title":"Innate immune recognition and control of adaptive immune responses","volume":"10","author":"Medzhitov","year":"1998","journal-title":"Semin Immunol"},{"issue":"6813","key":"10.1016\/j.vaccine.2005.07.105_bib2","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35047123","article-title":"A Toll-like receptor recognizes bacterial DNA","volume":"408","author":"Hemmi","year":"2000","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.vaccine.2005.07.105_bib3","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.4049\/jimmunol.167.7.3555","article-title":"Cutting edge: Role of Toll-like receptor 9 in CpG DNA-induced activation of human cells","volume":"167","author":"Takeshita","year":"2001","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2005.07.105_bib4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1574-695X.2001.tb00535.x","article-title":"CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young mice","volume":"32","author":"Weeratna","year":"2001","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2005.07.105_bib5","first-page":"204","article-title":"Recent advances in the development of immunostimulatory oligonucleotides","volume":"6","author":"Uhlmann","year":"2003","journal-title":"Curr Opin Drug Discov Devel"},{"issue":"4","key":"10.1016\/j.vaccine.2005.07.105_bib6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nri1329","article-title":"Immunotherapeutic uses of CpG oligodeoxynucleotides","volume":"4","author":"Klinman","year":"2004","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2005.07.105_bib7","doi-asserted-by":"crossref","first-page":"4494","DOI":"10.1128\/IAI.72.8.4494-4502.2004","article-title":"Immunostimulatory CpG oligodeoxynucleotide confers protection in a murine model of infection with Burkholderia pseudomallei","volume":"72","author":"Wongratanacheewin","year":"2004","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2005.07.105_bib8","doi-asserted-by":"crossref","first-page":"5148","DOI":"10.4049\/jimmunol.173.8.5148","article-title":"CpG oligodeoxynucleotides stimulate protective innate immunity against pulmonary Klebsiella infection","volume":"173","author":"Deng","year":"2004","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2005.07.105_bib9","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.4049\/jimmunol.160.6.2555","article-title":"Cutting edge: modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma","volume":"160","author":"Kline","year":"1998","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2005.07.105_bib10","doi-asserted-by":"crossref","first-page":"5906","DOI":"10.4049\/jimmunol.165.10.5906","article-title":"CpG oligodeoxynucleotides can reverse Th2-associated allergic airway responses and alter the B7.1\/B7.2 expression in a murine model of asthma","volume":"165","author":"Serebrisky","year":"2000","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2005.07.105_bib11","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s11912-004-0019-0","article-title":"Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotides","volume":"6","author":"Krieg","year":"2004","journal-title":"Curr Oncol Rep"},{"issue":"15","key":"10.1016\/j.vaccine.2005.07.105_bib12","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.1158\/0008-5472.CAN-04-0926","article-title":"CpG oligodeoxynucleotide enhances tumor response to radiation","volume":"64","author":"Milas","year":"2004","journal-title":"Cancer Res"},{"issue":"23\u201324","key":"10.1016\/j.vaccine.2005.07.105_bib13","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1016\/j.vaccine.2004.01.058","article-title":"Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine","volume":"22","author":"Cooper","year":"2004","journal-title":"Vaccine"},{"issue":"24","key":"10.1016\/j.vaccine.2005.07.105_bib14","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1016\/S0264-410X(03)00333-5","article-title":"Ex vivo human placenta models: transport of immunoglobulin G and its subclasses","volume":"21","author":"Malek","year":"2003","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2005.07.105_bib15","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0091-6749(03)01863-3","article-title":"Bacterial DNA in house and farm barn dust","volume":"112","author":"Roy","year":"2003","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2005.07.105_bib16","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1164\/rccm.2112062","article-title":"Airborne endotoxin predicts symptoms in non-mouse-sensitized technicians and research scientists exposed to laboratory mice","volume":"167","author":"Pacheco","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.vaccine.2005.07.105_bib17","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s004200050397","article-title":"Endotoxins and IgG antibodies as indicators of occupational exposure to the microbial contaminants of metal-working fluids","volume":"72","author":"Laitinen","year":"1999","journal-title":"Int Arch Occup Environ Health"},{"issue":"6","key":"10.1016\/j.vaccine.2005.07.105_bib18","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s004380050850","article-title":"On the fate of orally ingested foreign DNA in mice: chromosomal association and placental transmission to the fetus","volume":"259","author":"Schubbert","year":"1998","journal-title":"Mol Gen Genet"},{"issue":"3","key":"10.1016\/j.vaccine.2005.07.105_bib19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/ng0395-243","article-title":"Gene transfer and expression in progeny after intravenous DNA injection into pregnant mice","volume":"9","author":"Tsukamoto","year":"1995","journal-title":"Nat Genet"},{"issue":"9","key":"10.1016\/j.vaccine.2005.07.105_bib20","doi-asserted-by":"crossref","first-page":"5478","DOI":"10.4049\/jimmunol.167.9.5478","article-title":"Transplacental genetic immunization after intravenous delivery of plasmid DNA to pregnant mice","volume":"167","author":"Okuda","year":"2001","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2005.07.105_bib21","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.4049\/jimmunol.164.3.1617","article-title":"Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo","volume":"164","author":"Hartmann","year":"2000","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2005.07.105_bib22","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1365-2567.2004.01962.x","article-title":"Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation","volume":"113","author":"Vollmer","year":"2004","journal-title":"Immunology"},{"issue":"5","key":"10.1016\/j.vaccine.2005.07.105_bib23","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1034\/j.1600-0897.2003.00045.x","article-title":"MD-1 is a critical part of the mechanism causing Th1-cytokine-triggered murine fetal loss syndrome","volume":"49","author":"Clark","year":"2003","journal-title":"Am J Reprod Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2005.07.105_bib24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1006\/exer.1993.1003","article-title":"Genetic control of ocular morphogenesis: defective lens development associated with ocular anomalies in C57BL\/6 mice","volume":"56","author":"Robinson","year":"1993","journal-title":"Exp Eye Res"},{"issue":"7","key":"10.1016\/j.vaccine.2005.07.105_bib25","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S1567-5769(03)00093-6","article-title":"Maternal immune stimulation reduces both placental morphologic damage and down-regulated placental growth-factor and cell cycle gene expression caused by urethane: are these events related to reduced teratogenesis?","volume":"3","author":"Sharova","year":"2003","journal-title":"Int Immunopharmacol"},{"issue":"10","key":"10.1016\/j.vaccine.2005.07.105_bib26","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1097\/00006454-200110000-00005","article-title":"Safety and antibody persistence following Haemophilus influenzae type b conjugate or pneumococcal polysaccharide vaccines given before pregnancy in women of childbearing age and their infants","volume":"20","author":"Santosham","year":"2001","journal-title":"Pediatr Infect Dis J"},{"issue":"24","key":"10.1016\/j.vaccine.2005.07.105_bib27","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1016\/S0264-410X(03)00352-9","article-title":"Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women","volume":"21","author":"Munoz","year":"2003","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2005.07.105_bib28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0020-7292(99)00008-9","article-title":"Tetanus toxoid and congenital abnormalities","volume":"64","author":"Czeizel","year":"1999","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"10.1016\/j.vaccine.2005.07.105_bib29","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0029-7844(01)01384-9","article-title":"Varicella vaccine exposure during pregnancy: data from the first 5 years of the pregnancy registry","volume":"98","author":"Shields","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2005.07.105_bib30","first-page":"1768","article-title":"Influenza vaccination during pregnancy","volume":"48","author":"Goldman","year":"2002","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.vaccine.2005.07.105_bib31","unstructured":"EEC. Commission Directive 91\/507\/EEC of 19 July, 1991 modifying the Annex to Council Directive 75\/318\/EEC on the approximation of the laws of Member States relating to analytical, pharmacotoxicological and clinical standards and protocols in respect of the testing of medicinal products. EEC Official J 1991;L270:32\u201352."},{"issue":"2","key":"10.1016\/j.vaccine.2005.07.105_bib32","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1182\/blood-2004-06-2156","article-title":"Combination immunotherapy with a CpG oligonucleotide (1018 ISS) and rituximab in patients with non-Hodgkin lymphoma: increased interferon-alpha\/beta-inducible gene expression, without significant toxicity","volume":"105","author":"Friedberg","year":"2005","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.vaccine.2005.07.105_bib33","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/eji.200324032","article-title":"Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities","volume":"34","author":"Vollmer","year":"2004","journal-title":"Eur J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2005.07.105_bib34","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.4049\/jimmunol.165.8.4165","article-title":"Phosphorothioate backbone modification modulates macrophage activation by CpG DNA","volume":"165","author":"Sester","year":"2000","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2005.07.105_bib35","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1128\/IAI.72.6.3543-3548.2004","article-title":"CpG oligodeoxynucleotides improve the survival of pregnant and fetal mice following Listeria monocytogenes infection","volume":"72","author":"Ito","year":"2004","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2005.07.105_bib36","doi-asserted-by":"crossref","first-page":"6638","DOI":"10.1128\/IAI.70.12.6638-6645.2002","article-title":"Differences in expression of toll-like receptors and their reactivities in dendritic cells in BALB\/c and C57BL\/6 mice","volume":"70","author":"Liu","year":"2002","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2005.07.105_bib37","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0300-483X(02)00610-8","article-title":"Reproductive toxicology studies and immunotherapeutics","volume":"185","author":"Barrow","year":"2003","journal-title":"Toxicology"},{"issue":"3","key":"10.1016\/j.vaccine.2005.07.105_bib38","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0300-483X(02)00607-8","article-title":"Pregnancy and the immune system: between tolerance and rejection","volume":"185","author":"Thellin","year":"2003","journal-title":"Toxicology"},{"issue":"3","key":"10.1016\/j.vaccine.2005.07.105_bib39","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0264-410X(87)90103-4","article-title":"Synergistic teratogenic effect produced in mice by whole cell pertussis vaccine","volume":"5","author":"Au-Jensen","year":"1987","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2005.07.105_bib40","first-page":"197","article-title":"Experimental viral-induced congenital encephalopathies. I. Pathology of hydranencephaly and porencephaly caused by bluetongue vaccine virus","volume":"25","author":"Osburn","year":"1971","journal-title":"Lab Invest"},{"issue":"3","key":"10.1016\/j.vaccine.2005.07.105_bib41","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0264-410X(98)00051-6","article-title":"Exposure to yellow fever vaccine in early pregnancy","volume":"17","author":"Robert","year":"1999","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2005.07.105_bib42","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1046\/j.1365-3083.2002.01091.x","article-title":"Heme oxygenase is downregulated in stress-triggered and interleukin-12-mediated murine abortion","volume":"55","author":"Zenclussen","year":"2002","journal-title":"Scand J Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2005.07.105_bib43","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.4049\/jimmunol.160.9.4280","article-title":"TNF-alpha messenger RNA and protein expression in the uteroplacental unit of mice with pregnancy loss","volume":"160","author":"Gorivodsky","year":"1998","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2005.07.105_bib44","doi-asserted-by":"crossref","first-page":"545","DOI":"10.4049\/jimmunol.160.2.545","article-title":"Cytokine-dependent abortion in CBA\u00d7DBA\/2 mice is mediated by the procoagulant fgl2 prothrombinase [correction of prothombinase]","volume":"160","author":"Clark","year":"1998","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2005.07.105_bib45","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1600-0897.1997.tb00225.x","article-title":"Soluble receptors neutralizing TNF-alpha and IL-1 block stress-triggered murine abortion","volume":"37","author":"Arck","year":"1997","journal-title":"Am J Reprod Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2005.07.105_bib46","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0301-2115(03)00371-3","article-title":"Identification of the causes of intrauterine death during 310 consecutive autopsies","volume":"113","author":"Horn","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05007693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05007693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T08:08:33Z","timestamp":1683187713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X05007693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0264410X05007693"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2005.07.105","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}